|drug1092||Drug: Isotretinoin(Aerosolized 13 cis retinoic acid) plus Aerosolized Itraconazole Wiki||1.00|
|drug1091||Drug: Isotretinoin(Aerosolized 13 cis retinoic acid) Wiki||1.00|
|D003141||Communicable Diseases NIH||0.07|
There is one clinical trial.
Study of COVID-19 seroprevalence in precarious population living in shelters of Samusocial de Paris and in staff working in these centers during COVID-19 epidemic.
Description: Primary objective is to evaluate SARS-COV2 seroprevalence in people hosted and health care workers of 3 centers of Samusocial de Paris where COVID19 epidemics occuredMeasure: SARS-COV-2 seroprevalence in 3 centers for homeless and people in social distress Time: 6 months
Description: Measure of morbidity in the participating population in the 3 centersMeasure: Morbidity rate Time: 6 months
Description: Number of deaths related to Covid-19 during the epidemic in the 3 centersMeasure: Covid-19 related death rate in the 3 centers from March to May 2020 Time: 6 months
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports